PAVmed
PAVM
7 hedge funds and large institutions have $512K invested in PAVmed in 2018 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, 2 reducing their positions, and 9 closing their positions.
0% less ownership
Funds ownership: 0.01% → 0% (-0%)
38% less capital invested
Capital invested by funds: $829K → $512K (-$317K)
50% less funds holding
Funds holding: 14 → 7 (-7)
50% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 2
78% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 9
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$25.5K |
| 2 |
TSS
Two Sigma Securities
New York
|
+$19.6K |
| 3 |
GWS
Glassman Wealth Services
Vienna,
Virginia
|
+$8.32K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$40K |
| 2 |
Renaissance Technologies
New York
|
-$37.7K |
| 3 |
Millennium Management
New York
|
-$32K |
| 4 |
MSAM
Moloney Securities Asset Management
Manchester,
Missouri
|
-$21.1K |
| 5 |
VF
Virtu Financial
New York
|
-$17K |
PAVM Hedge Fund Activity: Q4 2018 in Review
7 of the 4,488 institutional investors tracked by Wall St. Rank reported a position in PAVmed (PAVM) for Q4 2018, worth a combined $512K — down 38% from $829K a quarter earlier.
Sellers outnumbered buyers: 9 funds closed out of PAVM and 2 opened new positions — a net loss of 7 holders — while 2 trimmed existing stakes and 1 added.
The largest buyer was Vanguard Group, adding an estimated $25.5K. The largest seller was Susquehanna International Group, exiting entirely with an estimated $40K sold.
- 7 institutional investors held PAVmed (PAVM) as of Q4 2018, down from 14 in Q3 2018.
- Funds reported $512K of PAVmed stock for Q4 2018, down 38% quarter-over-quarter.
- 2 funds opened new PAVmed positions in Q4 2018 and 9 closed out, a net change of -7 holders.
- The largest PAVmed buyer in Q4 2018 was Vanguard Group, an estimated $25.5K added.
- The largest PAVmed seller in Q4 2018 was Susquehanna International Group, an estimated $40K sold.
Based on aggregated 13F filings for Q4 2018.